Stock ILA ISLAND PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Island Pharmaceuticals Limited

Equities

ILA

AU0000138869

Delayed Australian S.E.
Other stock markets
 01:04:40 2024-07-15 am EDT 		5-day change 1st Jan Change
0.068 AUD -2.86% Intraday chart for Island Pharmaceuticals Limited +3.03% -28.42%
Jul. 03 Island Pharmaceuticals Acquiring Clinical-Stage Antiviral Molecule MT
May. 08 Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13% MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Island Pharmaceuticals Acquiring Clinical-Stage Antiviral Molecule
MT
Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13%
MT
Island Pharmaceuticals Reports Positive Data from Dose Study of Dengue Medication
MT
Island Pharmaceuticals to raise $1.95 million for ISLA-101 development
AQ
Island Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023
CI
Australia Shares Fall as Central Bank Keeps Rates Steady
MT
Island Pharmaceuticals Achieves Primary Endpoint in Dengue Drug Ascending Dose Study
MT
Island Pharmaceuticals Doses Subjects with Third Cohort for Dengue Medication Study
MT
Island Pharmaceuticals' ISLA-101 Study Advances to Third Cohort Dosing
MT
Island Pharmaceuticals Signs R&D Loan Deal With Radium Capital
MT
Island Pharmaceuticals Announces Change of Company Secretaries
CI
Island Pharmaceuticals Administers First Drug Cohort for Dengue Medication Study
MT
Island Pharma one step closer to ISLA-101 dosing
AQ
Island Pharmaceuticals Begins Screening for Dengue Medication Study
MT
Island Pharmaceuticals Gets Nearly AU$390,000 R&D Tax Rebate; Shares Fall 4%
MT
Island Pharma welcomes green light for ISLA-101 clinical study
AQ
Island Pharmaceuticals Receives Ethics Approval for Ascending Dose Study
MT
Island Pharmaceuticals Secures Australian Patent for Flavivirus Treatment
MT
Island Pharma gearing up to start ISLA-101 trial for dengue fever
AQ
Island Pharmaceuticals to Start Dengue Drug Trial in October
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ILA Stock
  4. News Island Pharmaceuticals Limited